Inhibition of human Vγ9Vδ2 T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer

HLA Class I Molecules Regulate IFN-  Production Induced in NK Cells by Target Cells, Viral Products, or Immature Dendritic Cells through the Inhibitory Receptor ILT2/CD85j

(2014) E. Morel et al.   JOURNAL OF IMMUNOLOGY

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

(2010) Laurence Amiot et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The role of HLA-G in immunity and hematopoiesis

(2010) Edgardo D. Carosella et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

(2010) E. M. de Kruijf et al.   JOURNAL OF IMMUNOLOGY

Human Vγ9Vδ2 T cells: From signals to functions

(2010) Steven Nedellec et al.   SEMINARS IN IMMUNOLOGY

Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma

(2009) Yu Abe et al.   EXPERIMENTAL HEMATOLOGY

ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse

(2009) Benoit Favier et al.   FASEB JOURNAL

Human melanoma cell secreting human leukocyte antigen–G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell

(2009) Emilie Lesport et al.   HUMAN IMMUNOLOGY

γδ T Cells and the Lymphoid Stress-Surveillance Response

(2009) Adrian C. Hayday   IMMUNITY

Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies

(2009) Ludovic Martinet et al.   IMMUNOLOGY LETTERS

IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V 9V 2 T Cells for Adoptive Immunotherapy

(2009) A. Thedrez et al.   JOURNAL OF IMMUNOLOGY

Characterization of HLA-G expression in renal cell carcinoma

(2009) B.-L. Li et al.   TISSUE ANTIGENS

Beyond the increasing complexity of the immunomodulatory HLA-G molecule

(2008) E. D. Carosella et al.   BLOOD

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

(2008) Jaafar Bennouna et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Bridging innate and adaptive immunity through gd T - dendritic cell crosstalk

(2008) Emmanuel Scotet   Frontiers in Bioscience-Landmark

Expression and regulation of non-classical HLA-G in renal cell carcinoma

(2008) K. Dunker et al.   TISSUE ANTIGENS

HLA-G: from biology to clinical benefits

(2008) Edgardo D. Carosella et al.   TRENDS IN IMMUNOLOGY